This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Retainer ring = black customer complaint about prime/fill anomaly alarms on (b)(6) 2022.The device passed the displacement test, rewind test, prime/seating test, basic occlusion test, force sensor test, occlusion test.And self-test.The device primed and seated properly when the test reservoir was detected.No prime/fill anomaly noted.All boluses delivered properly and were listed in the daily history.The device was programmed with multiple basal profiles and monitored.All basal profiles delivered their indicated amounts and were verified in the daily and summary history screens.Successfully downloaded history files using thus software.No unexpected occlusions or delivery anomaly, bolus anomaly or basal anomaly noted on download history file.The following were noted during visual inspection, fading serial number label.The unit p-cap / test reservoir locks in place properly.Unit was not confirmed for prime/fill anomalies.Unit passed all required testing medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|